scientific communications

In this episode of Causes or Cures, Dr. Eeks chats with Dr. Kyle Flanigan, CEO and co-founder of US Specialty Formulations about his company's work on creating a COVID-19 vaccine you can swallow. Basically, a vaccine you drink instead of a shot in the arm. He will discuss his company's vaccine platform, called QYNDR, and how it produces oral vaccines. He'll tell us what an oral vaccine is and how it differs from the traditional vaccines we are used to, including differences in immune response, storage, accessibility and scalability. Dr. Flanigan will walk us through how they are testing the vaccine, the funding requirements involved, early results from an early-stage trial in New Zealand, safety concerns, and what's in store for the future.

You can contact Dr. Eeks at bloomingwellness.com.
Follow Dr. Eeks on Instagram here.
Or Facebook here.
Or Twitter.
Subscribe to her newsletter here. 

The podcast objectives are to : 

1. explain what publication plain-language summaries are and how patients find them useful 
2. share patient experience of being involved in reviewing PLS, and key points to consider from a patient’s perspective when developing PLS  

Moderator: Karen King PhD CMPP, Head of Medical Strategy, Growth & Development, CMC Affinity, a McCann Health Company

Interviewee: Simon R. Stones BSc (Hons) MMRS, Health Advocate and Consultant, Collaboro Consulting